Maldives vs Montenegro: The number of people with susceptibility test result for rifampicin
Maldives
46
in 2021
Montenegro
55
in 2021
Maldives rank
123rd
Montenegro rank
121st
The number of people with susceptibility test result for rifampicin over time
- Maldives
- Montenegro
How they compare
Montenegro currently reports 55 against 46 in Maldives, a difference of 9.
That makes Montenegro's figure about 1.2 times Maldives's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Maldives ahead.
Maldives ranks 123rd and Montenegro ranks 121st of 155 countries.
Maldives has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Maldives | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 76 | 57 | 19 | Maldives |
| 2020s | 44.5 | 42 | 2.5 | Maldives |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Maldives or Montenegro?
- Montenegro, at 55 against 46 in Maldives as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Maldives and Montenegro?
- 9, with Montenegro ahead.
- How many years of comparable data are there for Maldives and Montenegro?
- 5 years are reported by both, from 2017 to 2021.
- How do Maldives and Montenegro rank globally for the number of people with susceptibility test result for rifampicin?
- Maldives ranks 123rd and Montenegro ranks 121st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.